economie7 %AstraZeneca's shares dropped nearly 7% following the announcement✓ Confirmed · 6 sources

AstraZeneca and Bristol Myers Squibb in talks for a $400 billion merger

AstraZeneca and Bristol Myers Squibb are exploring a merger valued at $400 billion.

Published 14sem6 sources✓ ConfirmedImportantupdated 13sem
Lire en français
≈ 16s

The fact

AstraZeneca's shares dropped nearly 7% following the announcement.

This merger would create a global pharmaceutical giant.

6 sources — click a link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Royaume-Uni · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 6 media sources · identified on August 3, 2026
← Back to home
Discover

Read more

All economie →